Munster P - Search Results

1

Discussion of fertility preservation with newly diagnosed patients: oncologists' views.

Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, Wilson C, Munster P. Quinn GP, et al. Among authors: munster p. J Cancer Surviv. 2007 Jun;1(2):146-55. doi: 10.1007/s11764-007-0019-9. J Cancer Surviv. 2007. PMID: 18648955

2

Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach.

Gwede CK, Small BJ, Munster PN, Andrykowski MA, Jacobsen PB. Gwede CK, et al. Support Care Cancer. 2008 Aug;16(8):925-33. doi: 10.1007/s00520-007-0364-2. Epub 2007 Nov 28. Support Care Cancer. 2008. PMID: 18043948 Free PMC article.

3

Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway.

Münster PN, Marchion DC, Basso AD, Rosen N. Münster PN, et al. Cancer Res. 2002 Jun 1;62(11):3132-7. Cancer Res. 2002. PMID: 12036925

4

Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.

Marchion DC, Bicaku E, Daud AI, Sullivan DM, Munster PN. Marchion DC, et al. Cancer Res. 2005 May 1;65(9):3815-22. doi: 10.1158/0008-5472.CAN-04-2478. Cancer Res. 2005. PMID: 15867379

5

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Donovan KA, et al. Among authors: munster p. Cancer. 2005 Dec 1;104(11):2499-507. doi: 10.1002/cncr.21482. Cancer. 2005. PMID: 16247788 Free PMC article.

6

Fatigue after treatment for early stage breast cancer: a controlled comparison.

Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Jacobsen PB, et al. Cancer. 2007 Oct 15;110(8):1851-9. doi: 10.1002/cncr.22993. Cancer. 2007. PMID: 17847016 Free PMC article.

7

Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling.

Biçaku E, Marchion DC, Schmitt ML, Münster PN. Biçaku E, et al. Cancer Res. 2008 Mar 1;68(5):1513-9. doi: 10.1158/0008-5472.CAN-07-2822. Cancer Res. 2008. PMID: 18316616

8

Cognitive functioning in breast cancer survivors: a controlled comparison.

Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Jim HS, et al. Cancer. 2009 Apr 15;115(8):1776-83. doi: 10.1002/cncr.24192. Cancer. 2009. PMID: 19224550 Free PMC article.

9

A single supratherapeutic dose of vorinostat does not prolong the QTc interval in patients with advanced cancer.

Munster PN, Rubin EH, Van Belle S, Friedman E, Patterson JK, Van Dyck K, Li X, Comisar W, Chodakewitz JA, Wagner JA, Iwamoto M. Munster PN, et al. Clin Cancer Res. 2009 Nov 15;15(22):7077-84. doi: 10.1158/1078-0432.CCR-09-1214. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887475 Clinical Trial.

10

First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.

Munster PN, Britten CD, Mita M, Gelmon K, Minton SE, Moulder S, Slamon DJ, Guo F, Letrent SP, Denis L, Tolcher AW. Munster PN, et al. Clin Cancer Res. 2007 Feb 15;13(4):1238-45. doi: 10.1158/1078-0432.CCR-06-1539. Clin Cancer Res. 2007. PMID: 17317835 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters